Anesthesia Modality in Intracranial Stenting for Acute Stroke—A Sub-Analysis of the RESISTANT International Registry

Read full text
Authors: João André Sousa, Marta Olivé‐Gadea, Francesco Diana, Johannes Kaesmacher, Adnan Mujanović, Serdar Geyik, Songül Şenadım, Amedeo Cervo, Andrea Salcuni, Mariangela Piano, Manuel Moreu, Alfonso López‐Frías
+60 more Ameer E Hassan, Samantha Miller, Elena Zapata‐Arriaza, Asier de Albóniga-Chindurza, Mauro Bergui, Stefano Molinaro, Fabio Gomes, João Sargento‐Freitas, Andrea Maria Alexandre, Alessandro Pedicelli, Jérémy Hofmeister, Paolo Machi, Luca Scarcia, Erwah Kalsoum, José Manuel Amorim, Torcato Meira, Santiago Ortega‐Gutiérrez, Aarón Rodríguez-Calienes, Leonardo Renieri, Francesco Capasso, Daniele Giuseppe Romano, Eduardo Bárcena, David Seoane, Mohamad K. Abdalkader, Piers Klein, Thanh Ngoc Nguyen, Catarina Perry, Isabel Fragata, Dileep R. Yavagal, Jude Hassan Charles, José Rodríguez Castro, Pedro Vega, Atilla Özcan Özdemir, Zehra Uysal Kocabaş, Stanislas Smajda, Sadiq Al Salman, Jane Khalife, Tudor G. Jovin, Francesco Biraschi, Francesca Ricchetti, Pedro Castro, Luis Albuquerque, Adnan Siddiqui, Vinay Jaikumar, Pedro Navía, Nikos Ntoulias, Marios‐Nikos Psychogios, Mariano Velo, Joaquín Zamarro, Gonzalo de Paco, Yazan K Ashouri, Mohammad AlMajali, Juan Francisco Arenillas, Alicia Sierra, Michele Romoli, João Pedro Marto, Shadi R. Yaghi, Marc Ribó, Alejandro Tomasello, Manuel Requena
Cited by: 0
References: 13

Abstract

PURPOSE: The optimal anesthetic approach for intracranial stenting in acute stroke remains unclear. We compared outcomes of patients under general anesthesia (GA) versus local anesthesia or conscious sedation. METHODS: The RESISTANT registry is a multicenter observational study on acute intracranial stenting during thrombectomy. Patients treated between January 2016 and June 2023 were included and stratified into GA and local anestesia/conscious sedation groups. The primary outcome was an adjusted shift analysis of the modified Rankin Scale (mRS) at 90 days. Secondary outcomes included mRS 0-2 at 90 days and final modified Thrombolysis in Cerebral Infarction (mTICI) 2c/3 scores. Safety outcomes were symptomatic intracranial hemorrhage (sICH) and mortality. Adjusted ordinal and logistic regression with mixed-effects models were performed. RESULTS: Of 876 patients, 445 (50.8%) received GA. Median age was 67 years [59-77]; 567 (64.8%) were men. No differences were found in 90-day mRS (adjusted common OR = 1.256 [0.887-1.780], p = 0.199). Rates of functional independence (39.0% vs 44.5%; aOR = 0.956 [0.606-1.507], p = 0.846), mTICI 2c/3 (68.9% vs 68.7%; aOR = 0.941 [0.602-1.471], p = 0.790), and sICH (8.0% vs 8.6%; aOR = 0.769 [0.374-1.584], p = 0.477) were comparable. In-hospital (23.0% vs 12.0%; aOR = 2.39 [1.35-4.22], p = 0.003) and 90-day mortality (33.3% vs 21.1%; aOR = 2.017 [1.227-3.315], p = 0.006) were higher in the GA group. CONCLUSION: In patients undergoing intracranial stenting during thrombectomy, anesthesia modality was not associated with better outcomes. GA was linked to higher mortality, likely due to indication bias.

Fields of Study & Subjects

Acute Ischemic Stroke Management Intracranial Aneurysms: Treatment and Complications Cerebrovascular and Carotid Artery Diseases

Publication details

Journal / source
Clinical Neuroradiology
Volume
36
Issue
2
Pages
635–645
Publication date
3 February 2026
Language
EN